Biotech in bearish trend

20. Dez. 2021

50sma has been an important moving average for this ETF.

We see 3 consecutive tests of the 50sma as resistance and a bounce lower.

As we see lower highs and lower lows, the bearish trend is confirmed.

I expect we fail again and test the blue line ($144.5).

11. Jan. 2022

Anmerkung

Another opportunity to short is presenting if we can't get above the $144.5 blue line again.

If we test it and head lower, the next target is $130

11. Feb. 2022

Trade geschlossen: Ziel wurde erreicht